SCI Abstract

search
Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
Calcinosis cutis is the deposition of insoluble calcium in the skin and subcutaneous tissues. It is a manifestation of sev...
Scleroderma as paraneoplastic disease: A new case of a rare association with renal cell carcinoma
Scleroderma as paraneoplastic disease: A new case of a rare association with renal cell carcinoma
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study
Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study
Objectives:The aim of this study was to identify and prioritize aspects essential for decision making in patients with dif...
The role of interleukin-17 in the pathogenesis of systemic sclerosis: Pro-fibrotic or anti-fibrotic?
The role of interleukin-17 in the pathogenesis of systemic sclerosis: Pro-fibrotic or anti-fibrotic?
Systemic sclerosis is characterized by widespread fibrosis of the skin and internal organs, vascular impairment, and dysre...
Circulating Gremlin-1 is elevated in systemic sclerosis patients
Circulating Gremlin-1 is elevated in systemic sclerosis patients
Introduction:Systemic sclerosis is an autoimmune connective tissue disease in which there is activation of the immune syst...
Is axillary botulinum toxin efficient in controlling secondary Raynaud’s phenomenon? A case report
Is axillary botulinum toxin efficient in controlling secondary Raynaud’s phenomenon? A case report
Raynaud’s phenomenon when secondary to underlying systemic disease such as systemic sclerosis occurs early in the disease ...